Articles By Amel Brahmi
For decades, cannabis has been sold in coffee shops, but illegal to grow. A government experiment, approved by the Senate this week, aims to resolve that tension.
Sativex and Epidyolex were approved for reimbursement by the NHS for some conditions. But health officials say product costs are too high, and benefits too low, for patients with chronic pain.
The government will soon have data to determine whether to approve medical cannabis use for pain relief.